Sectoral Asset Management’s Royalty Pharma RPRX Stock Holding History

Sectoral Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$404K	Hold	7,200	–	–	0.28%	63
2026 Q1	$394K	Sell	7,200 -1,270	-15%	-$55.6K	0.33%	62
2025 Q4	$327K	Sell	8,470 -810	-9%	-$30.9K	0.26%	67
2025 Q3	$327K	Hold	9,280	–	–	0.2%	73
2025 Q2	$334K	Hold	9,280	–	–	0.22%	78
2025 Q1	$289K	Buy	9,280 +2,080	+29%	+$65.9K	0.22%	64
2024 Q4	$184K	Sell	7,200 -9,230	-56%	-$245K	0.12%	79
2024 Q3	$465K	Sell	16,430 -220	-1%	-$6.09K	0.27%	66
2024 Q2	$439K	Sell	16,650 -2,770	-14%	-$76.8K	0.18%	70
2024 Q1	$590K	Sell	19,420 -1,150	-6%	-$33.9K	0.23%	63
2023 Q4	$578K	Buy	20,570 +2,620	+15%	+$72K	0.25%	72
2023 Q3	$487K	Buy	17,950 +2,588	+17%	+$76.9K	0.09%	107
2023 Q2	$472K	Buy	15,362 +2,922	+23%	+$99K	0.08%	108
2023 Q1	$448K	Hold	12,440	–	–	0.09%	104
2022 Q4	$492K	Buy	12,440 +300	+2%	+$12.5K	0.1%	103
2022 Q3	$488K	Sell	12,140 -1,700	-12%	-$72.6K	0.1%	88
2022 Q2	$582K	Buy	+13,840	New	+$567K	0.12%	91

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sectoral Asset Management's RPRX Position: Q2 2026 in Review

Sectoral Asset Management held its Royalty Pharma (RPRX) position steady in Q2 2026 at 7,200 shares worth $404K. The position accounts for 0.28% of the portfolio, ranked #63.

Sectoral Asset Management first reported a position in RPRX in Q2 2022 and has held it in 17 quarters since. The position peaked at $590K in Q1 2024. 644 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Sectoral Asset Management held 7,200 shares of Royalty Pharma worth $404K as of Q2 2026.
Sectoral Asset Management left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up 0.28% of Sectoral Asset Management's portfolio in Q2 2026, its #63 holding.
Sectoral Asset Management first reported a position in Royalty Pharma in Q2 2022 and has held it in 17 quarters since.
Sectoral Asset Management's Royalty Pharma position peaked at $590K in Q1 2024.
644 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.